About the Project |  FAQs |  Glossary |  Data Sources |  Bibliography |  Complete Indicator List

Indicator Details — Solid Organ Transplant Population: Status of Adult Kidney Transplant Recipients from a Deceased Donor at 1-Year Post-transplant
Data Sources
Stratification and Year Choices:

  • SRTR

  View Data By:
  Chart Format

  Chart Colors

Select a state from the dropdown below


Filter By:

Sort By:

In 2020 the proportion of all kidney transplant recipients with CKD (stages 3-5) and ESRD 1-year post-transplant was about 50%.

Chart Explanation: 

Since 1999, there appears to be a slight trend toward a lower prevalence of CKD stage 3-5 at 1 year post-transplant, among first kidney transplant recipients from deceased donors and correspondingly greater proportion of such recipients with an eGFR > 60ml/min/1.73 m².These data also suggest a slight reduction in the proportion of deaths in the first year post-deceased donor kidney transplant over this time period.

Individuals who received a solid organ transplant in the United States were followed up annually for assessment of their health status. These data are recorded in the Scientific Registry of Transplant Recipients (SRTR). All analyses presented are limited to adults aged 20 years or older at the time of their first organ transplant. These data are nationally-representative of the first-time, solid-organ transplant population with less than 5% lacking information on kidney function.

Diabetes status (type 1 or 2) and hypertension status are as listed at the time of transplant. For all transplant recipients, use of calcineurin inhibitors (CNI) to prevent transplant rejection is presented as many of these medications have been shown to be nephrotoxic1. The recording of data in the SRTR pertaining to CKD/kidney function varied by organ type and is discussed below.

Information on kidney transplant recipients included serum creatinine measurements for each follow-up visit as well as whether the patient has been treated for end-stage renal disease (ESRD) through dialysis or a kidney retransplant since the last follow-up. CKD stages 3-5 is defined by CKD-EPI equation eGFR <60 ml/min/1.73 m². Additional data collected for kidney transplant recipients includes donor type (deceased vs. living donor), and whether the donor was considered an expanded criteria donor (e.g., a donor that may have been advanced in age, had diabetes, or had prior infection with hepatitis B or C).

1Ojo AO. Renal disease in recipients of nonrenal solid organ transplantation. Semin Nephrol.2007;27(4):498-507. 
Description of MeasurePrevalence of CKD (by eGFR) and Renal Dysfunction
Data SourceScientific Registry of Transplant Recipients
Type of Data Source


Data SetSRTR
Health Care System DataNo
Regional or National?National
Demographic GroupSolid Organ Transplant Recipients
NumeratorPatients in denominator with eGFR<60 (Liver, Kidney) or ‘renal dysfunction’ (Thoracic) at time of follow-up.
DenominatorPatients with a valid follow-up code who had a first solid organ transplant between 1999 and 2017 and were at least 20 years old at time of transplant.
Definition of diagnosed CKDStage 3, eGFR 30-59 ml/min per 1.73 m² Stage 4, 15-29 ml/min per 1.73 m² Stage 5, <15 ml/min per 1.73 m²
Glomerular filtration rate

Estimated using CKD-EPI formula for calibrated creatinine:

GFR = 141 × min (Scr /κ, 1)α × max(Scr /κ, 1)-1.209 × 0.993Age × 1.018 [if female] × 1.159 [if black]

Primary Data Source IndicatorSerum Creatinine measurements/Renal Dysfunction indicator
Primary Indicator Method of MeasurementTransplant follow-up
Secondary (1) VariableType of organ transplant
Secondary (1) Indicator Method of MeasurementRegistry
Secondary (2) VariableAge
Secondary (2) Indicator Method of MeasurementRegistry
Secondary (3) VariableRace/ethnicity
Secondary (3) Indicator Method of MeasurementRegistry
Secondary (4) VariableGender
Secondary (4) Indicator Method of MeasurementRegistry
Secondary (5) VariableDiabetes
Secondary (5) Indicator Method of MeasurementRegistry
Secondary (6) VariableHypertension
Secondary (6) Indicator Method of MeasurementRegistry
Secondary (7) VariableCalcineurin Treatment
Secondary (7) Indicator Method of MeasurementRegistry
Secondary (8) VariableExpanded Criteria Donor Status
Secondary (8) Indicator Method of MeasurementRegistry
Frequency of Measurement (Primary)Multiple measurements per patient
Period Currently Available


Pending DataNone.
Additional Data Items of InterestTrends over time, other stratification variables of interest.
Limitations of IndicatorReporting of data across organ types is not consistent. Reporting of kidney function for thoracic recipients may be subjective. Serum creatinine measurements are only taken once per follow-up, probably resulting in a large standard error.
Analytical ConsiderationsMissing data on serum creatinine measurements may be informative.
References and Sources:

Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd